Skip to content
Get Naltrexone

Naltrexone in the United States

Choose the form before checking US coverage. Generic oral tablets and monthly Vivitrol follow different prescribing, billing, and administration routes. The useful insurance question names the product, diagnosis, benefit type, prior authorisation, and site-of-care fee.

  • Updated

Two forms create two very different practical routines

US patients may encounter oral naltrexone tablets (commonly 50 mg generics) or Vivitrol, a 380 mg extended-release injection administered by a healthcare professional.

Coverage depends on the exact plan and whether a product is billed through a pharmacy or medical benefit. A formulary listing is not the same as zero out-of-pocket cost; prior authorization, site-of-care rules, deductibles, and eligibility for assistance can all matter.

The current FDA Vivitrol label was revised in December 2025. It tells clinicians to discuss and strongly consider prescribing an opioid-overdose reversal agent, while emphasizing the risks of precipitated withdrawal, attempts to overcome blockade, and overdose after treatment is interrupted or stopped.

A person compares oral naltrexone and Vivitrol coverage routes with an adviser

Where treatment may begin in the USA

Availability and cost depend on the provider as well as the product.

  • Primary care. A primary-care clinician may assess and prescribe oral naltrexone. Tests, referral, and timing depend on recent opioids, health history, and local practice; same-day treatment should not be assumed.
  • Addiction or mental-health care. A specialist or substance-use service may help when the history is complex or when a monthly injection is being considered.
  • Community treatment programme. Programme services, medicines, counselling, grant support, and eligibility vary; FindTreatment.gov, the federal treatment locator, lists programmes by location and service. Ask whether oral naltrexone and Vivitrol are actually offered before travelling.
  • Telehealth plus local supply. State rules and provider policies change. Even when assessment occurs remotely, Vivitrol still requires in-person administration and oral pharmacy stock needs checking.

Verify coverage by plan type

Do not rely on national coverage percentages for an individual claim.

  1. Commercial insurance. Check the current formulary, prior authorization, deductible, site-of-care rule, and whether Vivitrol is billed under the medical or pharmacy benefit. Manufacturer assistance has eligibility and savings limits.
  2. Medicaid. For opioid use disorder, state Medicaid programmes must cover all FDA-approved medications, naltrexone included; Congress made that requirement permanent in 2024. For alcohol use disorder, ask the state plan, because prior authorization and preferred-drug rules vary. In both cases, ask about the exact NDC/J-code, indication, preferred alternatives, and administration fee.
  3. Medicare. Coverage may involve Part D or a medical benefit depending on product and setting. The Vivitrol co-pay savings program excludes anyone whose medicine costs are partly paid by a government programme, including Medicare (Part D included), Medicaid, VA and TRICARE; verify with the plan.
  4. Uninsured or cash pay. Request separate written prices for medicine, clinician visit, laboratory work, and injection administration. Ask federally qualified health centers (find one near you) and official patient-assistance programs about eligibility.
A patient and advisor verify four different medicine coverage pathways

Key FDA facts

Product and label facts checked 26 July 2026.

  • First oral approval: 1984. Initial US approval for opioid dependence.
  • Alcohol indication: 1994. Oral naltrexone approval expanded to alcohol dependence.
  • Vivitrol dose: 380 mg. Extended-release intramuscular injection every 4 weeks.
  • Current label revision: Dec 2025. FDA label date for Vivitrol safety information.

USA-specific questions

What does the Vivitrol label say before the first injection?

For alcohol dependence, patients should not be actively drinking at the first injection. For opioid dependence, the label recommends an adequate opioid-free interval. A urine test or naloxone challenge may inform assessment but does not guarantee that precipitated withdrawal cannot occur.

Will insurance cover targeted naltrexone?

Coverage is plan- and product-specific. Ask about the oral naltrexone product, diagnosis, quantity, and prior authorisation rather than assuming the plan covers or excludes a named dosing method.

Is there a generic extended-release injection?

The FDA approved an abbreviated application in 2023. Approval alone does not prove current marketing or local supply; ask the provider and check the live FDA product record.

Can the VA provide naltrexone?

Eligible veterans can ask their VA clinician about oral or extended-release naltrexone. Individual eligibility, clinical suitability, local availability, and copay rules still need confirmation.

How do tablets and Vivitrol change daily life?

A tablet creates a recurring at-home routine. Vivitrol removes the daily tablet decision but adds monthly appointments, injection-site monitoring, and a different billing pathway.

Can treatment begin through telehealth?

State law, clinician licensing, provider policy, and the required assessment all matter. Oral treatment may sometimes begin remotely; Vivitrol administration is in person.

Find a service, then run the exact coverage check

Use SAMHSA’s directory to find care. Before agreeing to a product, ask the plan and provider about medicine cost, administration, laboratory work, prior authorisation, and any assistance restrictions.

Search FindTreatment.govPrepare for Vivitrol questions

Sources

Checked .

  1. FDA Vivitrol prescribing information, revised December 2025 (PDF)
  2. Consolidated Appropriations Act, 2024: Medicaid and CHIP mental health and substance use disorder provisions explained — Georgetown University Center for Children and Families. The 2024 law made permanent the requirement to cover all FDA-approved medications for opioid use disorder. Checked 22 October 2026.
  3. VIVITROL Co-pay Savings Program terms and conditions — Alkermes. Excludes patients covered by government programmes that pay any part of medicine costs. Checked 22 October 2026.
  4. FindTreatment.gov — Substance Abuse and Mental Health Services Administration (SAMHSA)
  5. Find a health center — Health Resources and Services Administration (HRSA)
  6. Low-dose naltrexone: what is the evidence? A narrative review (introduction: FDA approval history) — Advances in Therapy, 2026. Oral naltrexone approved in 1984 for opioid use disorder, extended in 1994 to alcohol use disorder.
On this page
On this page